AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Dec 2001 03:28 PM
RNS
New Data on Arimidex
10 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
07 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
06 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
05 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
04 Dec 2001 04:00 PM
RNS
Director Shareholding
04 Dec 2001 04:00 PM
RNS
Director Shareholding
03 Dec 2001 08:16 AM
RNS
Annual Business Review - Pt 2
03 Dec 2001 08:15 AM
RNS
Annual Business Review - Pt 1
03 Dec 2001 07:01 AM
RNS
Purchase of Own Securities
30 Nov 2001 09:00 AM
RNS
Annual Business Review
30 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
29 Nov 2001 07:01 AM
RNS
Purchase of Own Securities
28 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
26 Nov 2001 03:10 PM
RNS
Zestril Market Exclusivity
26 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
21 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
20 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
19 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
16 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
13 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
12 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
02 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
31 Oct 2001 02:03 PM
RNS
Litigation Announcement
31 Oct 2001 07:00 AM
RNS
Purchase of Own Securities
30 Oct 2001 07:00 AM
RNS
Purchase of Own Securities
29 Oct 2001 07:00 AM
RNS
Purchase of Own Securities
24 Oct 2001 11:00 AM
RNS
3rd Qtr/9 Mths Results 2 of 2
24 Oct 2001 11:00 AM
RNS
3rd Qtr/9 Mths Results 1 of 2
23 Oct 2001 11:01 AM
RNS
Prilosec US Litigation
23 Oct 2001 09:00 AM
RNS
Notice of Results
19 Oct 2001 12:22 PM
RNS
Research Update
26 Sep 2001 07:00 AM
RNS
Purchase of Own Securities
25 Sep 2001 07:01 AM
RNS
Purchase of Own Securities
24 Sep 2001 04:10 PM
RNS
Directors' Dealings
24 Sep 2001 07:00 AM
RNS
Purchase of Own Securities
21 Sep 2001 07:00 AM
RNS
Purchase of Own Securities
18 Sep 2001 07:00 AM
RNS
Purchase of Own Securities
17 Sep 2001 03:15 PM
RNS
Regulatory Approval
13 Sep 2001 07:00 AM
RNS
Purchase of Own Securities
12 Sep 2001 07:00 AM
RNS
Purchase of Own Securities
11 Sep 2001 07:00 AM
RNS
Purchase of Own Securities
10 Sep 2001 07:01 AM
RNS
Purchase of Own Securities
07 Sep 2001 07:00 AM
RNS
Purchase of Own Securities
06 Sep 2001 07:01 AM
RNS
Purchase of Own Securities
05 Sep 2001 07:00 AM
RNS
Purchase of Own Securities
04 Sep 2001 07:00 AM
RNS
Purchase of Own Securities
31 Aug 2001 07:00 AM
RNS
Purchase of Own Securities
30 Aug 2001 07:00 AM
RNS
Purchase of Own Securities
28 Aug 2001 07:00 AM
RNS
Purchase of Own Securities
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100

Latest directors dealings